Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting
The International Journal of Tuberculosis and Lung Disease · 01.06.2026 · 30 (6) · 288-290
DOI: 10.5588/ijtld.25.0620 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.06.2026. Verfasst von N F Maranchick und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Pharmacokinetics Lab, College of Pharmacy, and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Infectious Disease Pharmacokinetics Lab, College of Pharmacy, and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Zitieren
APA
Maranchick, N. F., Peloquin, C. A., & Haley, C. A. (2026). Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting. The International Journal of Tuberculosis and Lung Disease, 30(6), 288-290. https://doi.org/10.5588/ijtld.25.0620
Vancouver
Maranchick NF, Peloquin CA, Haley CA. Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting. The International Journal of Tuberculosis and Lung Disease. 2026;30(6):288-290. doi:10.5588/ijtld.25.0620
BibTeX
@article{Maranchick2026,
author = {Maranchick, N F and Peloquin, C A and Haley, C A},
title = {Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
volume = {30},
number = {6},
pages = {288--290},
doi = {10.5588/ijtld.25.0620}
}
EUVIMED